Markus Müller
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy 44
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 8
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 11
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery 8
-
- Drug Transport and Resistance Mechanisms 44
-
- Pharmacological Effects and Toxicity Studies 36
-
- Epilepsy research and treatment 19
-
- Radiopharmaceutical Chemistry and Applications 11
- Co-authors
- Martin BrunnerOliver LangerChristian JoukhadarHartmut DerendorfMarkus ZeitlingerHans Georg EichlerBernhard X. MayerMartin Frossard
- Journals
- Antimicrobial Agents and Chemotherapy (11 papers)Clinical Pharmacology & Therapeutics (5 papers)European Journal of Clinical Pharmacology (5 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Markus Müller
129 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 138
- Pharmacology 1.7k
- Molecular Medicine 449
- Applied Microbiology and Biotechnology 174
- Clinical Biochemistry 479
- Pharmaceutical Science 369
Countries citing papers authored by Markus Müller
This map shows the geographic impact of Markus Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Müller more than expected).
Fields of papers citing papers by Markus Müller
This network shows the impact of papers produced by Markus Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Müller. The network helps show where Markus Müller may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Müller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 5 | |
| 2 | 2016 | 55 | |
| 3 | 2015 | 49 | |
| 4 | 2015 | 7 | |
| 5 | 2013 | 64 | |
| 6 | Positron emission tomography for use in microdosing studies | 2013 | 11 |
| 7 | 2013 | 43 | |
| 8 | 2012 | 23 | |
| 9 | 2012 | 22 | |
| 10 | 2010 | 7 | |
| 11 | 2009 | 89 | |
| 12 | 2007 | 27 | |
| 13 | 2007 | 33 | |
| 14 | 2004 | 55 | |
| 15 | 2002 | 53 | |
| 16 | 2001 | 89 | |
| 17 | 2000 | 13 | |
| 18 | 2000 | 37 | |
| 19 | 1998 | 21 | |
| 20 | 1995 | 10 |
About Markus Müller
Markus Müller is a scholar working on Pharmacology, Pharmaceutical Science and Pediatrics, Perinatology and Child Health, having authored 130 papers that have together received 5.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (44 papers), Antibiotics Pharmacokinetics and Efficacy (44 papers), Pharmacological Effects and Toxicity Studies (36 papers), Epilepsy research and treatment (19 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Bacterial Identification and Susceptibility Testing (11 papers), Antibiotic Resistance in Bacteria (8 papers) and Advancements in Transdermal Drug Delivery (8 papers). The work is most often cited by research in Pharmacology (1.7k citations), Molecular Medicine (449 citations) and Applied Microbiology and Biotechnology (174 citations). Markus Müller has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Martin Brunner, Oliver Langer, Christian Joukhadar, Hartmut Derendorf, Markus Zeitlinger, Hans Georg Eichler, Bernhard X. Mayer, Martin Frossard, Johann Stanek and Martin Bauer. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics, European Journal of Clinical Pharmacology, Nuclear Medicine and Biology and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.